Literature DB >> 32167990

Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis.

Lauren A Graybill1, Margaret Kasaro2, Kellie Freeborn3, Jennifer S Walker4, Charles Poole1, Kimberly A Powers1, Katie R Mollan1,5, Nora E Rosenberg6, Sten H Vermund7, Wilbroad Mutale8, Benjamin H Chi3.   

Abstract

OBJECTIVES: A previous meta-analysis reported high HIV incidence among pregnant and breast-feeding women in sub-Saharan Africa (SSA), but limited evidence of elevated risk of HIV acquisition during pregnancy or breast-feeding when compared with nonpregnant periods. The rapidly evolving HIV prevention and treatment landscape since publication of this review may have important implications for maternal HIV incidence.
DESIGN: Systematic review and meta-analysis.
METHODS: We searched four databases and abstracts from relevant conferences through 1 December 2018, for literature on maternal HIV incidence in SSA. We used random-effects meta-analysis to summarize incidence rates and ratios, and to estimate 95% prediction intervals. We evaluated potential sources of heterogeneity with random-effects meta-regression.
RESULTS: Thirty-seven publications contributed 100 758 person-years of follow-up. The estimated average HIV incidence rate among pregnant and breast-feeding women was 3.6 per 100 person-years (95% prediction interval: 1.2--11.1), while the estimated average associations between pregnancy and risk of HIV acquisition, and breast-feeding and risk of HIV acquisition, were close to the null. Wide 95% prediction intervals around summary estimates highlighted the variability of HIV incidence across populations of pregnant and breast-feeding women in SSA. Average HIV incidence appeared associated with age, partner HIV status, and calendar time. Average incidence was highest among studies conducted pre-2010 (4.1/100 person-years, 95% prediction interval: 1.1--12.2) and lowest among studies conducted post-2014 (2.1/100 person-years, 95% prediction interval: 0.7--6.5).
CONCLUSION: Substantial HIV incidence among pregnant and breast-feeding women in SSA, even in the current era of combination HIV prevention and treatment, underscores the need for prevention tailored to high-risk pregnant and breast-feeding women.

Entities:  

Mesh:

Year:  2020        PMID: 32167990      PMCID: PMC7275092          DOI: 10.1097/QAD.0000000000002487

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  64 in total

Review 1.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

2.  On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions.

Authors:  S Greenland; K O'Rourke
Journal:  Biostatistics       Date:  2001-12       Impact factor: 5.899

3.  Postnatal transmission of HIV-1 associated with breast abscess.

Authors:  P Van de Perre; D G Hitimana; A Simonon; F Dabis; P Msellati; P Karita; P Lepage
Journal:  Lancet       Date:  1992-06-13       Impact factor: 79.321

4.  Postpartum sexual abstinence in the era of AIDS in Ghana: prospects for change.

Authors:  K Awusabo-Asare; J K Anarfi
Journal:  Health Transit Rev       Date:  1997

5.  HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics.

Authors:  John Kinuthia; Alison L Drake; Daniel Matemo; Barbra A Richardson; Clement Zeh; Lusi Osborn; Julie Overbaugh; R Scott McClelland; Grace John-Stewart
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

6.  Cofactors for HIV-1 incidence during pregnancy and postpartum period.

Authors:  John Kinuthia; James N Kiarie; Carey Farquhar; Barbra Richardson; Ruth Nduati; Dorothy Mbori-Ngacha; Grace John-Stewart
Journal:  Curr HIV Res       Date:  2010-10       Impact factor: 1.581

7.  Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa.

Authors:  Dhayendre Moodley; Tonya Esterhuizen; Logan Reddy; Pravi Moodley; Bipraj Singh; Linda Ngaleka; Devan Govender
Journal:  J Infect Dis       Date:  2011-03-11       Impact factor: 5.226

8.  Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Jing Wang; Barbara Van Der Pol; Nancy Padian; Robert A Salata; Barbra A Richardson
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

9.  Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet HIV       Date:  2016-07-19       Impact factor: 12.767

10.  Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.

Authors:  Sarah-Jane Anderson; Peter Cherutich; Nduku Kilonzo; Ide Cremin; Daniela Fecht; Davies Kimanga; Malayah Harper; Ruth Laibon Masha; Prince Bahati Ngongo; William Maina; Mark Dybul; Timothy B Hallett
Journal:  Lancet       Date:  2014-07-19       Impact factor: 79.321

View more
  19 in total

1.  Alcohol use and intimate partner violence in HIV-uninfected pregnant women in Cape Town, South Africa.

Authors:  Dvora L Joseph Davey; Stanzi M Le Roux; Kirsty Brittain; Kathryn Dovell; Steve Shoptaw; Amanda P Miller; Tamsin K Phillips; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  AIDS Care       Date:  2021-09-08

2.  Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.

Authors:  Dvora Leah Joseph Davey; Kathryn Dovel; Susan Cleary; Nehaa Khadka; Nyiko Mashele; Miriam Silliman; Rufaro Mvududu; Dorothy C Nyemba; Thomas J Coates; Landon Myer
Journal:  BMC Public Health       Date:  2022-07-07       Impact factor: 4.135

Review 3.  Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.

Authors:  Dvora L Joseph Davey; Linda-Gail Bekker; Elizabeth A Bukusi; Benjamin H Chi; Sinead Delany-Moretlwe; Ameena Goga; Anne Drapkin Lyerly; Nyaradzo M Mgodi; Nelly Mugo; Landon Myer; Lisa M Noguchi; Lynda Stranix-Chibanda; Catherine Slack; Jillian Pintye
Journal:  Lancet HIV       Date:  2022-01-25       Impact factor: 16.070

Review 4.  Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection.

Authors:  Randy M Stalter; Jillian Pintye; Kenneth K Mugwanya
Journal:  Expert Opin Drug Saf       Date:  2021-05-28       Impact factor: 4.011

Review 5.  Accelerating progress towards the elimination of mother-to-child transmission of HIV: a narrative review.

Authors:  Benjamin H Chi; Dorothy Mbori-Ngacha; Shaffiq Essajee; Lynne M Mofenson; Fatima Tsiouris; Mary Mahy; Chewe Luo
Journal:  J Int AIDS Soc       Date:  2020-08       Impact factor: 5.396

6.  Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding.

Authors:  Lauren M Hill; Friday Saidi; Kellie Freeborn; K Rivet Amico; Nora E Rosenberg; Suzanne Maman; Twambilile Phanga; Mercy Tsidya; Sara Chirwa; Chifundo Zimba; Wilbroad Mutale; Benjamin H Chi
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

7.  PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.

Authors:  Connie Celum; Sybil Hosek; Mandisa Tsholwana; Sheetal Kassim; Shorai Mukaka; Bonnie J Dye; Subash Pathak; Nyaradzo Mgodi; Linda-Gail Bekker; Deborah J Donnell; Ethan Wilson; Krista Yuha; Peter L Anderson; Yaw Agyei; Heather Noble; Scott M Rose; Jared M Baeten; Jessica M Fogel; Adeola Adeyeye; Lubbe Wiesner; James Rooney; Sinead Delany-Moretlwe
Journal:  PLoS Med       Date:  2021-06-18       Impact factor: 11.069

8.  Combination adherence strategy to support HIV antiretroviral therapy and pre-exposure prophylaxis adherence during pregnancy and breastfeeding: protocol for a pair of pilot randomised trials.

Authors:  Friday Saidi; Wilbroad Mutale; Kellie Freeborn; Nora E Rosenberg; Lauren Aiko Graybill; Suzanne Maman; K Rivet Amico; Katie R Mollan; Twambilile Phanga; Beteniko Milala; Lauren M Hill; Allison M Gottwalt; Sam Phiri; Thoko Kalua; Benjamin H Chi
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

9.  Urgent appeal to implement pre-exposure prophylaxis for pregnant and breastfeeding women in South Africa.

Authors:  D L Joseph Davey; N Davies; Y Raphael; Y Pillay; L-G Bekker
Journal:  S Afr Med J       Date:  2021-10-06

10.  Contracting HIV or Contracting SAR-CoV-2 (COVID- 19) in Pregnancy? Balancing the Risks and Benefits.

Authors:  Dvora Joseph Davey; Linda-Gail Bekker; Thomas J Coates; Landon Myer
Journal:  AIDS Behav       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.